Risk factor
Resilient to price shocks
Profitability factor
Strong margins and returns
About
InBody Co.,Ltd is a global provider of advanced body composition analysis solutions. The company offers an extensive product line, including body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, along with specialized devices like the InBody Dial and various bands. These technologies are widely employed across diverse applications, such as medical specialties like nephrology, liver disease, and diabetes, as well as in nutrition and rehabilitation programs. Originally established in 1996 and headquartered in Seoul, South Korea, the company was formerly known as Biospace Co., Ltd.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, 'cheap'
Target Price
The average target price of 041830.KQ is 74000 and suggests 4.52% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recomme